Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Asthma / April 2005

Tip: Looking for answers? Try searching our database.

Cat Allergiy

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
Richard Friedel - 31 Mar 2005 07:44 GMT
Story from BBC NEWS:
http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/4379743.stm

Cat allergies 'could be blocked'
Scientists say they have developed a technique which could prevent
allergies caused by cats.

In the UK, pets are the second most important cause of allergy in the
home, and 50% of asthmatic children are allergic to cats.

The University of California, Los Angeles, team combined a fragment of
a human protein with a cat allergen.

Nature Medicine reports mice treated with the fused protein did not
develop allergic responses.

    We could use the same technique to target other allergies, including
peanut
Dr Andrew Saxon, University of California, Los Angeles

Cat allergen is present on very small particles that readily become
airborne when disturbed and are easily inhaled.

When a person experiences an allergic response, a chemical called IgE,
produced by the immune system in response to the presence of allergens
such as cat hair, binds to specific receptors on the surface of immune
cells.

This triggers the release of histamine in tissues in the body, causing
symptoms such as itching, sneezing and a runny eyes and nose.

Other immune-based therapies rely on frequent injections of allergens,
with the dose being gradually increased each time.

But this is a time-consuming process, which can cause serious reactions
in patients.

Trigger

The researchers were looking at ways of preventing the allergic
response and histamine production.

They were able to combine part of human immunoglobulin (IgG), a protein
which blocks allergic reactions, with a piece of cat allergen.

The fused protein connected with the IgG receptor on the surface of the
immune cell, telling it not to "explode" and release histamine.

It meant that this "stop" message was stronger than the "go" message,
which was created by the presence of the allergen in the body.

However, the immune system is still being exposed to the allergen, so
although it would still recognise it in future, it would be "retrained"
not to see it as something it should have an allergic response to.

Tests on mice showed those treated with the fusion protein did not
develop allergic airway inflammation in response to cat allergen.

Early stages

Researcher Dr Andrew Saxon said: "We wanted to create a system that
would prevent you from getting sick when you were exposed to an
allergen, but which could also be used to retrain the immune system in
the long run.

"We could use the same technique to target other allergies, including
peanut."

Philippa Major, assistant director of research at Asthma UK said: "This
is an interesting study but is still in the early stages of development
as no human studies have begun.

"This approach taken by the UCLA group does not modify the T cell
response and therefore the treatment would need to be administered on a
continuous basis to prevent symptoms .

"Currently a different, and potentially long term prevention approach
of a T cell vaccine for people with cat allergy is being developed by
Asthma UK research fellow Dr Mark Larché."
Story from BBC NEWS:
http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/4379743.stm
jackmallory@webtv.net - 01 Apr 2005 07:21 GMT
Hopeful news for the many.
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.